Loss of Sulfoglucuronyl and Other Neolactoglycolipids in Purkinje Cell Abnormality Murine Mutants

A significant reduction in the content of two members of the sulfoglucuronyl-neolacto series of glycolipids (SGGLs), 3-sulfoglucuronyl-lacto-N-neotetraosylceramide (SGGL-1) and 3-sulfoglucuronyl lacto-N-norhexaosylceramide (SGGL-2), in the cerebellum of the Purkinje cell abnormality mutants, Purkinje cell degeneration (pcd/pcd), lurcher (Lc/+), and staggerer (sg/sg), was also confirmed in the mildly affected nervous (nr/nr) mutant. The expression of SGGLs was studied during development of the pcd/pcd mutant cerebellum, and it was shown that the rate of decline in the level of SGGLs practically coincided with the loss of Purkinje cell perikarya. This indicated that SGGLs are primarily localized in Purkinje cells and that initially, at least, there is no genetic defect in the biosynthesis of SGGLs in the mutant. The precursors of SGGLs, viz., lacto-N-neotetraosylceramide (paragloboside) and lacto-N-norhexaosylceramide, as well as other glycolipids derived from these precursors, such as X-determinant fucoglycolipids and disialosyllacto-N-neotetraosylceramide, were also present in normal cerebellum. Levels of paragloboside and its other derivatives, similar to SGGLs, were also significantly reduced in the Purkinje cell abnormality mutants pcd/pcd, sg/sg, Lc/+, and nr/nr but were normal in other cerebellar mutants, such as quaking (qk/qk), weaver (wv/wv), and reeler (rl/rl), where Purkinje cells are not involved. Thus, the entire paragloboside family of glycolipids is primarily associated with Purkinje cells in the cerebellum. Although levels of monoclonal antibody HNK-1-reactive glycolipids were reduced in the Purkinje cell abnormality mutants, HNK-1-reactive glycoproteins were not affected in these mutants.     

Activin-like signal activates dorsal-specific maternal RNA between 8- and 16-cell stages of Xenopus

In many animals the dorsalventral axis forms by an initial localization of maternal molecules, which then regulate the spatial location of signals that directly influence the expression of axis-specific fates. Several recent studies have demonstrated that dorsal-animal blastomeres of the Xenopus morula (8–32 cells) are biased toward dorsal fates prior to mesoderm inductive signaling In this study we ask whether the dorsal bias is the result of autonomous expression of maternal molecules specifically localized within dorsal cells or of early activating signals. It was found that although 16-cell dorsal-animal blastomeres (D1.1) can differentiate into dorsal tissues when cultured alone, the 8-cell mothers (D1) can not. Likewise, although RNA extracted from D1.1 can induce an extra dorsal axis when injected into vegetal blastomeres, RNA extracted from D1 can not. However, D1 does express dorsal tissues if co-cultured with dorsal-vegetal cells or with culture medium containing a mixture of activins (PIF-medium). Furthermore, short-term culture of D1 in PIF-medium enables the D1 RNA to induce an ectopic dorsal axis. Ven ral-animal blastomeres also can express dorsal axial tissues when co-cultured with dorsal-vegetal blastomeres or in PIF-medium, but the RNA from the activin-treated ventral cells cannot induce ectopic dorsal axes. These studies demonstrate that there are maternal RNAs that, shortly after fertilization are present only in the dorsalanimal region. They do not act cell autonomously, but require an activin-like signal. These RNAs may function by increasing the responsiveness of dorsal-animal blastomeres to the mesoderm inductive signals present in both the morula and the blastula. © Wiley-Liss, Inc.     

Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use

Background aimsThe manufacture of multipotential stromal cell (MSC)-based products is costly; therefore, a rapid evaluation of bone marrow (BM) ‘quality’ with respect to MSC content is desirable. The aim of this study was to develop a rapid single-platform assay to quantify MSC in BM aspirates.MethodsAspirated MSC were enumerated using the CD45^?/low CD271^bright phenotype and AccuCheck counting beads and compared with a classic colony-forming unit–fibroblast (CFU-F) assay. The phenotype of CD45^?/low CD271^bright cells was defined using a range of MSC (CD73, CD105, CD90) and non-MSC (CD31, CD33, CD34, CD19) markers. The effect of aspirated BM volume on MSC yield was also determined.ResultsCD45^?/low CD271^bright cells had a classic MSC phenotype (CD73⁺ CD105⁺ CD90⁺ ). Their numbers correlated positively with CFU-F counted manually (R = 0.81, P < 0.001) or using automatic measurements of surface area occupied by colonies (R = 0.66, P < 0.001). Simultaneous enumeration of CD34 ⁺ cells revealed donor variability ranges compatible with standard International Society of Hematotherapy and Graft Engineering (ISHGE) protocols. Aspirating larger marrow volumes gave a significant several-fold reduction in the frequency of CFU-F and CD45^?/low CD271^bright cells per milliliter. Therefore aspirated MSC yields can be maximized through a standardized, low-volume harvesting technique.ConclusionsAbsolute quantification of CD45^?/low CD271^bright cells was found to be a reliable method of predicting CFU-F yields in BM aspirates. This rapid (< 40 min) procedure could be suitable for intra-operative quality control of BM aspirates prior to volume reduction/direct injection in orthopedics. In the production of culture-expanded MSC, this assay could be used to exclude samples containing low numbers of MSC, resulting in improved consistency and quality of manufactured MSC batches.     

Assessing the frequency and drivers of early‐greening in broad‐leaved woodlands along a latitudinal gradient in southern Africa

Savannas are the only deciduous system where new leaf flush pre‐empts the onset of suitable conditions for growth, a phenological phenomenon known as early‐greening. Limited understanding of the frequency and drivers of the occurrence of early‐greening in southern African savanna trees exists. We aimed to estimate the frequency of early‐greening events across southern Africa and investigated potential environmental drivers of green‐up. We selected and compared seven broad‐leaved woodland sites where Burkea africana was a dominant species using remotely sensed data along a latitudinal gradient from South Africa to Zambia. Normalized difference vegetation index (NDVI) values were extracted from the Moderate Resolution Imaging Spectroradiometer (MODIS) satellite imagery at each site from January 2002 to June 2014. Using an austral year (July 1st–June 30th), early‐greening was recorded if the green‐up start date occurred prior to the onset date of seasonal rainfall. A latitudinal gradient of early‐green‐up was detected across southern Africa (R² = 0.74) with the two most northerly (Zambian) sites showing the earliest and most consistent green‐up start dates (3 October ± 5.34 days). A strong latitudinal gradient was observed between the variability in the amount of rainfall in the first 6 months of green‐up and the green‐up start dates across southern Africa (R² = 0.92). Photoperiod appeared to play a role in areas where the onset of rainfall commenced late into the austral year. Mean maximum temperatures recorded 10 days prior to green‐up start dates suggested a potential threshold of about 35°C, which could drive early‐greening in the absence of rainfall. Correlations between the proportion of early‐greening years and the above mentioned environmental factors indicated that rainfall variability had the strongest influence over the observed phenological gradient (R² = 0.96). Understanding early‐greening in complex savanna systems is a vital step in furthering predictive phenological models under changing climatic conditions.     

Genes Contributing to Pain Sensitivity in the Normal Population: An Exome Sequencing Study

Sensitivity to pain varies considerably between individuals and is known to be heritable. Increased sensitivity to experimental pain is a risk factor for developing chronic pain, a common and debilitating but poorly understood symptom. To understand mechanisms underlying pain sensitivity and to search for rare gene variants (MAF<5%) influencing pain sensitivity, we explored the genetic variation in individuals'' responses to experimental pain. Quantitative sensory testing to heat pain was performed in 2,500 volunteers from TwinsUK (TUK): exome sequencing to a depth of 70× was carried out on DNA from singletons at the high and low ends of the heat pain sensitivity distribution in two separate subsamples. Thus in TUK1, 101 pain-sensitive and 102 pain-insensitive were examined, while in TUK2 there were 114 and 96 individuals respectively. A combination of methods was used to test the association between rare variants and pain sensitivity, and the function of the genes identified was explored using network analysis. Using causal reasoning analysis on the genes with different patterns of SNVs by pain sensitivity status, we observed a significant enrichment of variants in genes of the angiotensin pathway (Bonferroni corrected p = 3.8×10⁻⁴). This pathway is already implicated in animal models and human studies of pain, supporting the notion that it may provide fruitful new targets in pain management. The approach of sequencing extreme exome variation in normal individuals has provided important insights into gene networks mediating pain sensitivity in humans and will be applicable to other common complex traits.     

Taking neural crest stem cells to new heights

The carotid body is an organ of the peripheral nervous system that senses oxygen concentration in the blood and responds to changes by regulating breathing. Pardal et al. (2007) now report the discovery of carotid body stem cells, which proliferate in response to hypoxia and generate neurons that secrete dopamine. This new source of adult stem cells may be useful in therapies for treating Parkinson's disease.     

An evaluation of the action of thioesterases on the surface of wool

The thioesterase activity of palmitoyl protein thioesterase (PPT1) and six commercial lipases was measured against the synthetic substrates, S-palmitoyl-N-acetylcysteamine (Ac-Cym-Pal) and S-(18-methyleicosanoyl)-N-acetylcysteamine (Ac-Cym-18-MEA). PPT1 showed good activity against Ac-Cym-Pal but relatively low activity against the longer chain substrate, Ac-Cym-18-MEA. The highest activity was given by Lipolase 100L type EX (Novozyme) and Lipoprotein Lipase (Sigma) with greater than 90% hydrolysis of Ac-Cym-18-MEA within 10 min at pH 7.4. Other lipases to show high levels of thioesterase activity include Lipex 100L (Novozyme), Lipomod 34P (Biocatalysts) and Lipozyme CALB L (Novozyme). Chemical analysis of wool fibre and fabric treated with the above enzymes under optimal conditions showed that there was no hydrolysis of 18-MEA or other covalently bound fatty acids from the fibre surface. No change in the wettability of the fabric surface was observed following enzyme treatments. Scanning electron micrographs of the fabric treated with the most active enzyme, Lipolase 100L type EX, revealed that the surface of the fibres appeared to have a coating that was not removed by extensive extraction. Reasons for the inability of PPT1 and the other esterases to hydrolyse 18-MEA from the wool fibre surface are discussed.     

Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral reflux

Congenital anomalies of the kidney and urinary tract (CAKUT) include vesicoureteral reflux (VUR). VUR is a complex, genetically heterogeneous developmental disorder characterized by the retrograde flow of urine from the bladder into the ureter and is associated with reflux nephropathy, the cause of 15% of end-stage renal disease in children and young adults. We investigated a man with a de novo translocation, 46,X,t(Y;3)(p11;p12)dn, who exhibits multiple congenital abnormalities, including severe bilateral VUR with ureterovesical junction defects. This translocation disrupts ROBO2, which encodes a transmembrane receptor for SLIT ligand, and produces dominant-negative ROBO2 proteins that abrogate SLIT-ROBO signaling in vitro. In addition, we identified two novel ROBO2 intracellular missense variants that segregate with CAKUT and VUR in two unrelated families. Adult heterozygous and mosaic mutant mice with reduced Robo2 gene dosage also exhibit striking CAKUT-VUR phenotypes. Collectively, these results implicate the SLIT-ROBO signaling pathway in the pathogenesis of a subset of human VUR.